Clinical Trial Update: Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tolerability and efficacy of erythropoietin versus methylprednisolone in spinal cord injury; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Erythropoietin (erythropoietin)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Niguarda Hospital | Conditions: Spinal Cord Injury | Phase 3 | Status: TERMINATED